Clinical Manifestations and Therapeutic Strategies in Lumbar Spondylosis: A Comprehensive Review
1,1*V. P. Nage, S. V. Chawre and 2*R. L. Shirole
1,1*Department of Kayachikitsa, Government Ayurvedic College, Nagpur - 440024 (India) 2Department of Pharmacology DCS’s A.R.A. College of Pharmacy, Dhule - 424005 (India) *Corresponding author : 1Dr. S.V. Chawre 1*Email id: sushilvilaschawre@gmail.com *Corresponding author : 2Dr. Shirole R. L. (M. Pharm., Ph.D.) 2Email id: rahulshirole@gmail.com Tel: 02562-2243021
ABSTRACT
Low back pain (LBP) represents a highly prevalent musculoskeletal condition, affecting approximately 60–85% of individuals at some point during their lifetime. In the majority of cases, symptoms are mild and self-limiting, with nearly 90% resolving within six weeks. However, chronic low back pain, defined as pain persisting for more than three months, affects an estimated 15–45% of the population and is associated with substantial impairments in quality of life and significant socioeconomic burden. Despite its high prevalence, the diagnostic evaluation and management of LBP remain heterogeneous and often inconsistent, contributing to increased healthcare costs and variability in clinical practice. This variability is largely attributable to the multifactorial nature of LBP, wherein a definitive etiology is difficult to establish, as nociceptive sources may arise from multiple structures within the axial spine. Consequently, LBP has often been described as “a condition in search of a precise diagnosis.”